These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 22004230
1. Leflunomide in clinical practice. A retrospective observational study on use of leflunomide in New Zealand. Jagoda JS, Rajapakse CN. Int J Rheum Dis; 2011 Oct; 14(4):340-4. PubMed ID: 22004230 [Abstract] [Full Text] [Related]
2. Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis. Rodriguez-Rodriguez L, Jover-Jover JA, Fontsere O, Peña-Blanco RC, León L, Fernández-Gutierrez B, Abásolo L. Scand J Rheumatol; 2013 Oct; 42(6):433-6. PubMed ID: 23742043 [Abstract] [Full Text] [Related]
3. Step-up combination versus switching of non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational study. Schoels M, Kapral T, Stamm T, Smolen JS, Aletaha D. Ann Rheum Dis; 2007 Aug; 66(8):1059-65. PubMed ID: 17307765 [Abstract] [Full Text] [Related]
4. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial. Bao C, Chen S, Gu Y, Lao Z, Ni L, Yu Q, Xu J, Li X, Liu J, Sun L, He P, Ma J, Xu S, Ding C. Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395 [Abstract] [Full Text] [Related]
5. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis. Bird P, Griffiths H, Tymms K, Nicholls D, Roberts L, Arnold M, Burnet S, de Jager J, Scott J, Zochling J, Littlejohn G. J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457 [Abstract] [Full Text] [Related]
6. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study. Flendrie M, Creemers MC, Welsing PM, van Riel PL. Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707 [Abstract] [Full Text] [Related]
7. Leflunomide-associated infections in rheumatoid arthritis. Jenks KA, Stamp LK, O'Donnell JL, Savage RL, Chapman PT. J Rheumatol; 2007 Nov; 34(11):2201-3. PubMed ID: 17937473 [Abstract] [Full Text] [Related]
8. Leflunomide treatment in elderly patients with rheumatoid or psoriatic arthritis: retrospective analysis of safety and adherence to treatment. Alivernini S, Mazzotta D, Zoli A, Ferraccioli G. Drugs Aging; 2009 Nov; 26(5):395-402. PubMed ID: 19552491 [Abstract] [Full Text] [Related]
9. Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis. Narváez J, Díaz-Torné C, Ruiz JM, Hernández MV, Torrente-Segarra V, Ros S, Rodriguez de la Serna A, Díaz-López C, Sanmartí R, Nolla JM. Semin Arthritis Rheum; 2011 Dec; 41(3):401-5. PubMed ID: 21862107 [Abstract] [Full Text] [Related]
10. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis. Lie E, van der Heijde D, Uhlig T, Heiberg MS, Koldingsnes W, Rødevand E, Kaufmann C, Mikkelsen K, Kvien TK. Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904 [Abstract] [Full Text] [Related]
11. Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: the GLADAR experience. Cardiel MH, Pons-Estel BA, Sacnun MP, Wojdyla D, Saurit V, Marcos JC, Pinto MR, Cordeiro de Azevedo AB, da Silveira IG, Radominski SC, Ximenes AC, Massardo L, Ballesteros F, Rojas-Villarraga A, Oñate RV, Hernandez MP, Esquivel-Valerio JA, García-De La Torre I, Khoury VJ, Millán A, Soriano ER, GLADAR. J Clin Rheumatol; 2012 Oct; 18(7):327-35. PubMed ID: 23047532 [Abstract] [Full Text] [Related]
12. Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study. Aletaha D, Stamm T, Kapral T, Eberl G, Grisar J, Machold KP, Smolen JS. Ann Rheum Dis; 2003 Oct; 62(10):944-51. PubMed ID: 12972472 [Abstract] [Full Text] [Related]
13. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V. Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358 [Abstract] [Full Text] [Related]
14. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide. Strangfeld A, Hierse F, Kekow J, von Hinueber U, Tony HP, Dockhorn R, Listing J, Zink A. Ann Rheum Dis; 2009 Dec; 68(12):1856-62. PubMed ID: 19126559 [Abstract] [Full Text] [Related]
17. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice. Van Roon EN, Jansen TL, Mourad L, Houtman PM, Bruyn GA, Griep EN, Wilffert B, Tobi H, Brouwers JR. Br J Clin Pharmacol; 2004 Jun; 57(6):790-7. PubMed ID: 15151525 [Abstract] [Full Text] [Related]
18. Adverse events with disease modifying antirheumatic drugs (DMARD): a cohort study of leflunomide compared with other DMARD. Cannon GW, Holden WL, Juhaeri J, Dai W, Scarazzini L, Stang P. J Rheumatol; 2004 Oct; 31(10):1906-11. PubMed ID: 15468352 [Abstract] [Full Text] [Related]
19. Rheumatoid arthritis, alcohol, leflunomide and methotrexate. Can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified? Rajakulendran S, Gadsby K, Deighton C. Musculoskeletal Care; 2008 Dec; 6(4):233-45. PubMed ID: 18702106 [Abstract] [Full Text] [Related]